- Home
- ROMA vs TLSA Comparison
ROMA vs TLSA Comparison
Compare ROMA & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROMA
- TLSA
- Stock Information
- Founded
- ROMA 2018
- TLSA 2013
- Country
- ROMA Hong Kong
- TLSA United Kingdom
- Employees
- ROMA N/A
- TLSA N/A
- Industry
- ROMA Savings Institutions
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- ROMA Finance
- TLSA Health Care
- Exchange
- ROMA Nasdaq
- TLSA Nasdaq
- Market Cap
- ROMA 160.8M
- TLSA 187.0M
- IPO Year
- ROMA 2024
- TLSA 2000
- Fundamental
- Price
- ROMA $2.65
- TLSA $2.06
- Analyst Decision
- ROMA
- TLSA
- Analyst Count
- ROMA 0
- TLSA 0
- Target Price
- ROMA N/A
- TLSA N/A
- AVG Volume (30 Days)
- ROMA 53.1K
- TLSA 541.9K
- Earning Date
- ROMA 09-02-2025
- TLSA 05-06-2025
- Dividend Yield
- ROMA N/A
- TLSA N/A
- EPS Growth
- ROMA N/A
- TLSA N/A
- EPS
- ROMA N/A
- TLSA N/A
- Revenue
- ROMA $1,568,345.00
- TLSA N/A
- Revenue This Year
- ROMA N/A
- TLSA N/A
- Revenue Next Year
- ROMA N/A
- TLSA N/A
- P/E Ratio
- ROMA N/A
- TLSA N/A
- Revenue Growth
- ROMA 23.21
- TLSA N/A
- 52 Week Low
- ROMA $0.50
- TLSA $0.63
- 52 Week High
- ROMA $4.66
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- ROMA 42.54
- TLSA 53.26
- Support Level
- ROMA $2.56
- TLSA $1.73
- Resistance Level
- ROMA $2.81
- TLSA $2.53
- Average True Range (ATR)
- ROMA 0.27
- TLSA 0.20
- MACD
- ROMA -0.03
- TLSA -0.05
- Stochastic Oscillator
- ROMA 25.25
- TLSA 41.25
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.